A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury

Kidney International

Volumn 71, Issue 12, 2007, Pages 1223-1231

  Lai, L W ^a   Yong, K C ^a   Igarashi, S ^a   Lien, Y H H ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Chemokine; EDG1; Ischemic renal injury; Lymphocyte; Renal lymphatics; S1P

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERFERON; SEW 2871; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG;

AGONIST; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL AGGREGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HISTOPATHOLOGY; INFLAMMATION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PERFUSION; LYMPHATIC SYSTEM; LYMPHOCYTE COUNT; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; REPERFUSION INJURY; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINES; FLUORESCENT ANTIBODY TECHNIQUE; KIDNEY; KIDNEY PELVIS; LYMPHOPENIA; MALE; MICE; OXADIAZOLES; RECEPTORS, LYSOSPHINGOLIPID; REPERFUSION INJURY; THIOPHENES;

EID: 34250007403     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002203     Document Type: Article

References (42)

1. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210.
2. Molitoris BA, Sutton TA. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int 2004; 66: 496-499.
3. Rabb H, Daniels F, O'Donnell M et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2000; 279: F525-F531.
4. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66: 486-491.
5. Day YJ, Huang L, Ye H et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol 2006; 176: 3108-3114.
6. Ysebaert DK, De Greef KE, De Beuf A et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004; 66: 491-496.
7. Burne MJ, Daniels F, El Ghandour A et al. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108: 1283-1290.
8. Yokota N, Daniels F, Crosson J et al. Protective effect of T cell depletion in murine renal ischemia-reperfusion injury. Transplantation 2002; 74: 759-763.
9. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-445.
10. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004; 22: 891-928.
11. Stein JV, Nombela-Arrieta C. Chemokine control of lymphocyte trafficking: a general overview. Immunology 2005; 116: 1-12.
12. Lemay S, Rabb H, Postler G et al. Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation 2000; 69: 959-963.
13. Miura M, Fu X, Zhang QW et al. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/ reperfusion injury. Am J Pathol 2001; 159: 2137-2145.
14. Fiorina P, Ansari MJ, Jurewicz M et al. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol 2006; 17: 716-723.
15. Furuichi K, Wada T, Iwata Y et al. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol 2003; 14: 2503-2515.
16. Brinkmann V, Cyster JG, Hla T. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 2004; 4: 1019-1025.
17. Sanchez T, Estrada-Hernandez T, Paik JH et al. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem 2003; 278: 47281-47290.
18. Sanna MG, Liao J, Jo E et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 2004; 279: 13839-13848.
19. Jo E, Sanna MG, Gonzalez-Cabrera PJ et al. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem Biol 2005; 12: 703-715.
20. Dragun D, Bohler T, Nieminen-Kelha M et al. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury. Kidney Int 2004; 65: 1076-1083.
21. Lien YH, Yong KC, Cho C et al. S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int 2006; 69: 1601-1608.
22. Awad AS, Ye H, Huang L et al. Selective sphingosine 1-phosphate 1 (S1P1) receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2006; 296: F1516-F1524.
23. Matloubian M, Lo CG, Cinamon G et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004; 427: 355-360.
24. Rosen H, Goetzl EJ. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 2005; 5: 560-570.
25. Krishnaswamy G, Kelley J, Yerra L et al. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 1999; 19: 91-104.
26. McVerry BJ, Garcia JG. Endothelial cell barrier regulation by sphingosine 1-phosphate. J Cell Biochem 2004; 92: 1075-1085.
27. De Greef KE, Ysebaert DK, Dauwe S et al. Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int 2001; 60: 1415-1427.
28. Albertine KH, O'Morchoe CC. Distribution and density of the canine renal cortical lymphatic system. Kidney Int 1979; 16: 470-480.
29. Rabb H. The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int 2002; 61: 1935-1946.
30. Togel F, Isaac J, Hu Z et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005; 67: 1772-1784.
31. Poznansky MC, Olszak IT, Foxall R et al. Active movement of T cells away from a chemokine. Nat Med 2000; 6: 543-548.
32. Ascon DB, Lopez-Briones S, Liu M et al. Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol 2006; 177: 3380-3387.
33. Graeler M, Goetzl EJ. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J 2002; 16: 1874-1878.
34. Dorsam G, Graeler MH, Seroogy C et al. Transduction of multiple effects of sphingosine 1-phosphate (S1P) on T cell functions by the S1P1 G protein-coupled receptor. J Immunol 2003; 171: 3500-3507.
35. Wei SH, Rosen H, Matheu MP et al. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol 2005; 6: 1228-1235.
36. Park P, Haas M, Cunningham PN et al. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am J Physiol Renal Physiol 2002; 282: F352-F357.
37. Faubel S, Ljubanovic D, Poole B et al. Peripheral CD4 T-cell depletion is not sufficient to prevent ischemic acute renal failure. Transplantation 2005; 80: 643-649.
38. Burne-Taney MJ, Yokota-Ikeda N, Rabb H. Effects of combined T- and B-cell deficiency on murine ischemia reperfusion injury. Am J Transplant 2005; 5: 1186-1193.
39. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003; 4: 397-407.
40. Tolle M, Levkau B, Keul P et al. Immunomodulator FTY720 Induces eNOSdependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ Res 2005; 96: 913-920.
41. Melnikov VY, Ecder T, Fantuzzi G et al. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 2001; 107: 1145-1152.
42. Lee CT, Shang S, Lai LW et al. Effect of thiazide on renal gene expression of apical calcium channels and calbindins. Am J Physiol Renal Physiol 2004; 287: F1164-F1170.